Phio Pharmaceuticals
PHIO
PHIO
17 hedge funds and large institutions have $1.58M invested in Phio Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
18% more capital invested
Capital invested by funds: $1.34M → $1.58M (+$240K)
0.01% more ownership
Funds ownership: 0.03% → 0.05% (+0.01%)
Holders
17
Holding in Top 10
–
Calls
$724K
Puts
$479K
Top Buyers
| 1 | +$348K | |
| 2 | +$98K | |
| 3 | +$95K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$65K |
| 5 |
Two Sigma Advisers
New York
|
+$63.4K |
Top Sellers
| 1 | -$355K | |
| 2 | -$48K | |
| 3 | -$24.3K | |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$11K |
| 5 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$6K |